These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 10430212)
1. Effect of antiretroviral therapy on recent trends in selected cancers among HIV-infected persons. Adult/Adolescent Spectrum of HIV Disease Project Group. Jones JL; Hanson DL; Dworkin MS; Ward JW; Jaffe HW J Acquir Immune Defic Syndr; 1999 Aug; 21 Suppl 1():S11-7. PubMed ID: 10430212 [TBL] [Abstract][Full Text] [Related]
2. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. International Collaboration on HIV and Cancer J Natl Cancer Inst; 2000 Nov; 92(22):1823-30. PubMed ID: 11078759 [TBL] [Abstract][Full Text] [Related]
3. Impact of potent antiretroviral therapy on the incidence of Kaposi's sarcoma and non-Hodgkin's lymphomas among HIV-1-infected individuals. Multicenter AIDS Cohort Study. Jacobson LP; Yamashita TE; Detels R; Margolick JB; Chmiel JS; Kingsley LA; Melnick S; Muñoz A J Acquir Immune Defic Syndr; 1999 Aug; 21 Suppl 1():S34-41. PubMed ID: 10430217 [TBL] [Abstract][Full Text] [Related]
4. Kaposi's sarcoma and non-Hodgkin's lymphoma incidence trends in AIDS Clinical Trial Group study participants. Rabkin CS; Testa MA; Huang J; Von Roenn JH J Acquir Immune Defic Syndr; 1999 Aug; 21 Suppl 1():S31-3. PubMed ID: 10430216 [TBL] [Abstract][Full Text] [Related]
5. Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998. Eltom MA; Jemal A; Mbulaiteye SM; Devesa SS; Biggar RJ J Natl Cancer Inst; 2002 Aug; 94(16):1204-10. PubMed ID: 12189223 [TBL] [Abstract][Full Text] [Related]
6. AIDS-related cancer and severity of immunosuppression in persons with AIDS. Biggar RJ; Chaturvedi AK; Goedert JJ; Engels EA; J Natl Cancer Inst; 2007 Jun; 99(12):962-72. PubMed ID: 17565153 [TBL] [Abstract][Full Text] [Related]
7. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S; J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006 [TBL] [Abstract][Full Text] [Related]
8. The impact of highly active antiretroviral therapy on the incidence and outcomes of AIDS-defining cancers in Southern Alberta. Gingues S; Gill MJ HIV Med; 2006 Sep; 7(6):369-77. PubMed ID: 16903981 [TBL] [Abstract][Full Text] [Related]
9. Cancer risk in people infected with human immunodeficiency virus in the United States. Engels EA; Biggar RJ; Hall HI; Cross H; Crutchfield A; Finch JL; Grigg R; Hylton T; Pawlish KS; McNeel TS; Goedert JJ Int J Cancer; 2008 Jul; 123(1):187-94. PubMed ID: 18435450 [TBL] [Abstract][Full Text] [Related]
11. Effect of highly active antiretroviral therapy on the incidence of HIV-associated malignancies at an urban medical center. Sparano JA; Anand K; Desai J; Mitnick RJ; Kalkut GE; Hanau LH J Acquir Immune Defic Syndr; 1999 Aug; 21 Suppl 1():S18-22. PubMed ID: 10430213 [TBL] [Abstract][Full Text] [Related]
12. Decreasing rates of Kaposi's sarcoma and non-Hodgkin's lymphoma in the era of potent combination anti-retroviral therapy. Grulich AE; Li Y; McDonald AM; Correll PK; Law MG; Kaldor JM AIDS; 2001 Mar; 15(5):629-33. PubMed ID: 11317001 [TBL] [Abstract][Full Text] [Related]
14. Incidence and trends in Kaposi's sarcoma in the era of effective antiretroviral therapy. Jones JL; Hanson DL; Dworkin MS; Jaffe HW J Acquir Immune Defic Syndr; 2000 Jul; 24(3):270-4. PubMed ID: 10969352 [TBL] [Abstract][Full Text] [Related]
15. Assessing the impact of HAART on the incidence of defining and non-defining AIDS cancers among patients with HIV/AIDS: a systematic review. Cobucci RN; Lima PH; de Souza PC; Costa VV; Cornetta Mda C; Fernandes JV; Gonçalves AK J Infect Public Health; 2015; 8(1):1-10. PubMed ID: 25294086 [TBL] [Abstract][Full Text] [Related]
16. Change in Pattern of Secondary Cancers After Kaposi Sarcoma in the Era of Antiretroviral Therapy. Mukhtar F; Ilozumba M; Utuama O; Cimenler O JAMA Oncol; 2018 Jan; 4(1):48-53. PubMed ID: 28837714 [TBL] [Abstract][Full Text] [Related]
17. AIDS and non AIDS-related malignant lymphoma in Tanzania. Kaaya EE; Castaños-Velez E; Ekman M; Mwakigonja A; Carneiro P; Lema L; Kitinya J; Linde A; Biberfeld P Afr Health Sci; 2006 Jun; 6(2):69-75. PubMed ID: 16916294 [TBL] [Abstract][Full Text] [Related]
19. Reduced incidence of Kaposi's sarcoma and of systemic non-hodgkin's lymphoma in HIV-infected individuals treated with highly active antiretroviral therapy. Carrieri MP; Pradier C; Piselli P; Piche M; Rosenthal E; Heudier P; Durant J; Serraino D Int J Cancer; 2003 Jan; 103(1):142-4. PubMed ID: 12455069 [No Abstract] [Full Text] [Related]
20. AIDS malignancies 1999: a tale of three viruses. Mascolini M J Int Assoc Physicians AIDS Care; 1999 Aug; 5(8):22-7, 32-8. PubMed ID: 11367308 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]